AUG 05, 2020 8:33 AM PDT

New Drug Prevents Inherited Alzheimer's in Mice

WRITTEN BY: Annie Lennon

Researchers at the Salk Institute have developed a new drug candidate that has successfully prevented Alzheimer's-related memory loss in mice. 

Known as CMS121, it is a synthesized form of fisetin, a chemical found in fruits and vegetables. While it has previously been shown to slow down aging in brain cells, the new study shows that it is also able to prevent memory loss by changing how brain cells metabolize fatty molecules. 

For the research, the researchers studied mice with an inherited condition similar to Alzheimer's. While one group of mice received daily doses of CMS121 at nine months old- the equivalent of being 'middle-aged'- the other group acted as a control and did not receive the drug. The researchers also monitored a control group without the genetic condition. 

After three months, all groups of mice underwent several memory and behavior tests. In both kinds of tests, the researchers found that the mice who had received CMD121 tended to perform as well as healthy control animals. Meanwhile, the untreated mice with the disease tended to perform worse. 

To understand how the drug worked, the researchers compared the neurochemistry of the three groups of mice. In doing so, they found that untreated mice had high levels of lipid peroxidation- the degradation of lipids that produce free radical molecules that can go on to damage cells. Meanwhile, both treated and healthy mice had lower levels of lipid peroxidation. 

As such, the researchers concluded that CMS121 lowered levels of lipid-producing fatty-molecule called fatty acid synthase (FASN), which then went on to reduce levels of lipid peroxidation. Given that brain samples of human patients who have died from Alzheimer's tend to exhibit higher amounts of FASN, the researchers say that FASN could be a new drug target for Alzheimer's disease. 

While the researchers themselves are now progressing into clinical trials, they hope that other researchers will investigate other compounds that target the FASN and lipid peroxidation. 

 

Sources: Neuroscience NewsScience Direct

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
AUG 11, 2020
Drug Discovery & Development
Scientists Discover Key Gene Behind Antibiotic Resistance
AUG 11, 2020
Scientists Discover Key Gene Behind Antibiotic Resistance
Scientists from Oxford University have shown that a single gene can make some strains of Staphylococcus aureus (the bact ...
AUG 16, 2020
Cannabis Sciences
Cannabinoids May Interact with Prescribed Medications
AUG 16, 2020
Cannabinoids May Interact with Prescribed Medications
Despite the growing popularity of cannabis products, information is currently limited on how they may interact with othe ...
AUG 16, 2020
Drug Discovery & Development
Could Cat Drugs Treat COVID-19 in Humans?
AUG 16, 2020
Could Cat Drugs Treat COVID-19 in Humans?
While COVID-19 may not affect cats much, felines are known to contract another kind of coronavirus that can sometimes be ...
SEP 08, 2020
Space & Astronomy
New Drug May Allow Astronauts to Spend Years in Space
SEP 08, 2020
New Drug May Allow Astronauts to Spend Years in Space
Without gravity from Earth, muscles and bones tend to weaken quickly. To combat this, astronauts usually need to spend t ...
SEP 10, 2020
Drug Discovery & Development
Improving Chemotherapeutic Delivery
SEP 10, 2020
Improving Chemotherapeutic Delivery
One particular form of stubborn cancer, known as hepatocellular carcinoma, has been challenging to treat and as a result ...
SEP 21, 2020
Drug Discovery & Development
Metformin Does Not Work in All Type 2 Diabetics
SEP 21, 2020
Metformin Does Not Work in All Type 2 Diabetics
Although metformin is the first-line drug for type-2 diabetics, research shows that it is not always effective for all t ...
Loading Comments...